AN2 Therapeutics
Price & Volume
Stats
See more52W Range | $1-$1.79 |
Market Cap | $46.8M |
Shares Short | 53,144 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.13 |
News
See moreYahoo Finance • 4 months ago
AN2 Therapeutics reports Q3 results
Yahoo Finance • 7 months ago
AN2 Therapeutics’ SWOT analysis: stock’s potential amid pipeline setbacks
About
CEO | Mr. Eric E. Easom |
CFO | Ms. Lucy O. Day CPA |
Address | 1800 El Camino Real, Menlo Park, CA, United States, 94027 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 22 |
